133 related articles for article (PubMed ID: 38241695)
21. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation.
Zhu Y; Xiao B; Liu M; Chen M; Xia N; Guo H; Huang J; Liu Z; Wang F
Cell Mol Biol Lett; 2023 Oct; 28(1):89. PubMed ID: 37891494
[TBL] [Abstract][Full Text] [Related]
22. The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases.
Chen Z; Zhong X; Xia M; Zhong J
Mol Ther Nucleic Acids; 2021 Dec; 26():1270-1279. PubMed ID: 34853726
[TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.
Peng WX; Liu F; Jiang JH; Yuan H; Zhang Z; Yang L; Mo YY
Genes Dis; 2023 Mar; 10(2):554-567. PubMed ID: 37223505
[TBL] [Abstract][Full Text] [Related]
24. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
25. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract][Full Text] [Related]
26. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
27. The m
Diao H; Tan H; Hu Y; Wang R; Cai P; Huang B; Shao X; Yan M; Yin C; Zhang Y
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259333
[TBL] [Abstract][Full Text] [Related]
28. HIF-1α-induced expression of the m6A reader YTHDF1 inhibits the ferroptosis of nucleus pulposus cells by promoting SLC7A11 translation.
Lu X; Li D; Lin Z; Gao T; Gong Z; Zhang Y; Wang H; Xia X; Lu F; Song J; Xu G; Jiang J; Ma X; Zou F
Aging Cell; 2024 May; ():e14210. PubMed ID: 38783692
[TBL] [Abstract][Full Text] [Related]
29. Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits.
Zhang L; Cheng Y; Xue Z; Li J; Wu N; Yan J; Wang J; Wang C; Chen W; Zhou T; Qiu Z; Jiang H
Cell Biol Toxicol; 2022 Apr; 38(2):347-369. PubMed ID: 33928466
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhao X; Chen Y; Mao Q; Jiang X; Jiang W; Chen J; Xu W; Zhong L; Sun X
Cancer Biomark; 2018; 21(4):859-868. PubMed ID: 29439311
[TBL] [Abstract][Full Text] [Related]
31. YTHDF1 promotes intrahepatic cholangiocarcinoma progression via regulating EGFR mRNA translation.
Huang X; Zhu L; Wang L; Huang W; Tan L; Liu H; Huo J; Su T; Zhang M; Kuang M; Li X; Dai Z; Xu L
J Gastroenterol Hepatol; 2022 Jun; 37(6):1156-1168. PubMed ID: 35233828
[TBL] [Abstract][Full Text] [Related]
32. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
33. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644
[TBL] [Abstract][Full Text] [Related]
34. YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.
Bai Y; Yang C; Wu R; Huang L; Song S; Li W; Yan P; Lin C; Li D; Zhang Y
Front Oncol; 2019; 9():332. PubMed ID: 31131257
[TBL] [Abstract][Full Text] [Related]
35. The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma.
Bai S; Zhao Y; Chen W; Peng W; Wang Y; Xiong S; Aruna ; Li Y; Yang Y; Chen S; Cheng B; Wang R
J Transl Med; 2023 Mar; 21(1):236. PubMed ID: 37004088
[TBL] [Abstract][Full Text] [Related]
36. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
37. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
38. YTHDF1 Protects Auditory Hair Cells from Cisplatin-Induced Damage by Activating Autophagy via the Promotion of ATG14 Translation.
Huang Y; Gao D; Wu Y; Sun L; Chen J; Chen J; Huang X; Yang J; Li S
Mol Neurobiol; 2022 Dec; 59(12):7134-7151. PubMed ID: 36097301
[TBL] [Abstract][Full Text] [Related]
39. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
Kong F; Wang K; Wang L
Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
[TBL] [Abstract][Full Text] [Related]
40. RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation.
Hao WY; Lou Y; Hu GY; Qian CY; Liang WR; Zhao J; Wang XH
Biochem Biophys Res Commun; 2022 Aug; 616():76-81. PubMed ID: 35649302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
